Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)

Clinical trial NCT06087835 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06087835
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Kidney Disease With High Proteinuria

Start date: 2023-11-07
Primary completion: 2027-02-18
Enrollment: 1835

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.